Location History:
- Kiryat Tivon, IL (2003 - 2007)
- Tivon, IL (2014)
Company Filing History:
2 out of 963 
2 out of 5 Years Active: 2003-2014
Title: Arie Admon: Innovator in Cancer Detection Technologies
Introduction
Arie Admon is a notable inventor based in Kiryat Tivon, Israel. He has made significant contributions to the field of cancer detection, holding a total of 4 patents. His work focuses on innovative methods for diagnosing and treating various types of cancer, particularly those affecting the gastrointestinal tract.
Latest Patents
One of his latest patents involves the development of markers for cancer detection. This invention relates to methods for detecting, prognosing, and staging cancers, specifically targeting cancers of the gastrointestinal tract. The methods include detecting specific protein markers in tissue samples, which can indicate pre-cancerous or cancerous conditions, as well as the stage or prognosis of the disease. Additionally, he has developed cancer detection kits and methods for treating cancer. Another significant patent is for placental protein 13 (PP13), which includes the full amino acid and DNA sequences of this protein. The invention describes various PP13-derived peptide fragments and a recombinant method for producing PP13, which can be utilized in screening and diagnostic methods for pregnancy-related complications.
Career Highlights
Throughout his career, Arie Admon has worked with esteemed organizations such as Technion Research & Development Foundation Limited and Diagnostic Technologies Ltd. His experience in these companies has allowed him to advance his research and contribute to the development of innovative medical technologies.
Collaborations
Arie has collaborated with notable individuals in his field, including Eilon Barnea and Ilan Beer. These partnerships have further enhanced his research and development efforts in cancer detection technologies.
Conclusion
Arie Admon's contributions to cancer detection and treatment exemplify the impact of innovative thinking in the medical field. His patents and collaborations reflect a commitment to advancing healthcare solutions.